Udit Batra, PhD, CEO of MilliporeSigma, recently spoke with GEN Edge reporter Alex Philippidis about the growth of life sciences, and ongoing challenges in 2020 . . .
- Bioprocessing
- Bioprocessing Operations
- Cell Therapy
- China
- GEN Edge
- Genome Editing
- Gene Therapy
- Industry News
- Merck KGaA
- MilliporeSigma
- News
Looking Beyond Bioprocessing to China, eCommerce, New Tech, and Services
Edge Exclusive Q&A: Udit Batra, PhD, MilliporeSigma CEO, Says Life Sciences Business of Merck KGaA Poised for Growth after Strong Quarter
“With our end-to-end portfolio of products, we definitely have been gaining market share, and that business has been growing very, very nicely,” says Udit Batra, PhD, CEO of MilliporeSigma and member of the Executive Board, Merck KGaA, Darmstadt, Germany. [MilliporeSigma]
